Follow the event on twitter #IGBAMedicinesforEU
Lucia Romagnoli - T: +44-7562-876873 - E: [email protected]
www.medicinesforeurope.com/events
PROGRAMME
Patients
increasing patient
access
Quality
quality, safety and
efficacy
Value
investors in
innovation
Sustainability
160.000 jobs across
Europe
Partnership
key partners for
public health
Wednesday 14 June
16:30
-
18:30
--PRICING & REIMBURSEMENT--
Pre-Conference Workshop 1: Pricing and Reimbursement Policies around Generic Medicines
Chair | Michele Uda, Director General – Assogenerici and Chair EMAC – Medicines for Europe
Panel
Helder Mota-Filipe, Associate Professor of Faculty of Pharmacy, University of Lisbon and former
Member of the Executive Board – National Authority of Medicines and Health Products (Infarmed
I.P.)
Jaime Espin, Professor – Andalusian School of Public Health
Giovanni Tafuri, Senior HTA Officer – Italian Medicines Agency (AIFA)
Németh Gergely, Project Manager – National Health Insurance Fund of Hungary (OEP)
Victor Lino Mendonça, Head of Policy and Market Access Europe – Mylan
16:30
-
18:30
--ETHICS--
Pre-Conference Workshop 2: International Consensus Framework on Ethics in the Healthcare Sector
Chair | Michael Fadus, Vice President of Compliance – Teva
Panel
Ema Paulino, Professional Secretary FIP Executive Committee and President Lisbon and South
Branch of the Portuguese Pharmaceutical Society
Robert Andrew Johnstone, Patient Advocate
Christophe Lesguer, CCO, Chief Compliance Officer Europe – Mylan GmbH
Heikki Pälve, CEO – Finnish Medical Association
Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com
Follow us on
16:30
-
18:30
--COMMUNICATIONS--
Pre-Conference Workshop 3: #AccessHealth, what’s behind a hashtag?
Chair | John Gisborne, Managing Director and Senior Partner – FleishmanHillard Fishburn
Panel
Aidan Fry, Editor – Generics Bulletin
Paul Tunnah, CEO and Founder – Pharmaphorum
Laetitia Tonel, Head of Communications – Mylan Europe
Chris Lewis, Senior Manager External Communications – Sandoz Global Communications
James Duggan, Principal Medical Writer – 90TEN/IGBA Biosimilar Medicines Communication Project
Evan O’Connell, Communications and Public Affairs Specialist – Aspect Consulting
16:30
-
18:30
--TRADE--
Pre-Conference Workshop 4: Business Opportunities in External Markets and Access to Medicines –
An Assessment of the International Affairs Committee
Chair | Sergio Napolitano, Legal and External Relations Director – Medicines for Europe
Panel
Alan Sheppard, Principal, Global Generics and Biosimilars, Thought Leadership – QuintilesIMS
Alejandro Ollé, Partner and Co-founder – Galenicum
David Jauch, Senior Manager Global Regulatory Affairs, Government Relations – Fresenius Kabi
Oleh Syarkevych, Business Development Director – Farmak JSC
Natalia Matting, Lawyer – DG Trade, European Commission
Koen Nauwelaerts, Quality and Regulatory Manager – Medicines for Europe
20:00
Welcome Cocktail sponsored by and Conference Registrations
Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com
Follow us on
Thursday 15 June
08:00
Welcome Coffee and Registration
09:00
--OPENING ADDRESS--
Jacek Glinka, President – Medicines for Europe
--OPENING KEYNOTE SPEECH--
Maria do Céu Machado, President – INFARMED
09:30
--SUSTAINABILITY--
Better Access, Better Health: our Industry’s Vision on Sustainability of Healthcare
Chair | Adrian van den Hoven, Director General – Medicines for Europe
Panel
Rabia Khan, Health Policy Analyst – OECD
Christa Cepuch, Pharmacist Coordinator – MSF Access Campaign
Alex Harris, CEO – International Health Partners
Robert Andrew Johnstone, Patient Advocate
Pierluigi Antonelli, Head Western Europe – Sandoz International
Jacek Glinka, President Europe – Mylan
11:00
Networking Coffee break
11:40
--DEVELOPED MARKETS--
Global Update of Generic Medicines in Developed Markets
Chair | Jim Keon, President – Canadian Generic Pharmaceutical Association and President, Biosimilars
Canada
Panel
Alan Sheppard, Principal Thought Leadership Global Generics and Biosimilars – QuintilesIMS
Kyozo Inari, Executive Corporate Officer – Sawai Pharmaceutical Co., Ltd. and Chair of International
Affairs Committee – JGA
John McCullough, VP Commercial Generics Europe and Global In Line Portfolio Management – Teva
Tony Mauro, Chief Commercial Officer – Mylan
13:00
Networking Buffet Lunch sponsored by
Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com
Follow us on
14:00
--GLOBAL MANUFACTURING--
Making Generic and Biosimilar Manufacturing
Thrive: A Global Policy
Chair | Michele Uda, Director General –
Assogenerici and Chair EMAC – Medicines for
Europe
Panel
Gian Mario Baccalini, President –
Aschimfarma and Chair – European Fine
Chemicals Group
Dinesh Dua, Vice Chairman –
Pharmaceuticals Export Promotion
Council of India
Satoshi Kawamura, Senior Vice
President – Nipro Pharma Corporation
Jody Cox, Vice President Federal and
International Affairs, Canadian Generic
Pharmaceutical Association and Vice
President, Biosimilars Canada
--PROCUREMENT--
A Concerted Approach to Tackle Economic and
Regulatory Aspects of Shortages
Chair | Marc-Alexander Mahl, Executive Vice President,
Business Unit Generic Drugs – Fresenius Kabi and Chair
of the Hospital Working Group – Medicines for Europe
Panel
Annie Pannelay, Principal – The Economist
Intelligence Unit
Maggie Dolan, Regional Pharmacy Procurement
Specialist – NHS Commercial Solutions Surrey
Aida Batista, Board Member, Director of
Professional Development – European Association
of Hospital Pharmacists
Marcel T. M. van Raaij, Director Ministry of
Health – The Netherlands
Dominik Tomek, Board Member – European
Patients Forum
Yi-Yun (April) Wang, Legal Manager - Yung Shin
Pharm. Ind. Co., Ltd. and Chair, International
Affairs Committee – Taiwan Generic
Pharmaceutical Association
15:20
Networking Coffee Break
16:00
--INTERNATIONAL CONVERGENCE--
International Regulatory and Supply Chain
Cooperation
Chair | David Gaugh, Senior Vice President,
Sciences and Regulatory Affairs – AAM
Panel
Sabine Kopp, Group Lead, Medicines
Quality Assurance – WHO
Brendan Cuddy, Head of Manufacturing
and Quality Compliance – EMA
Nuala Calnan, Senior Associate –
Lachman Consultant Services, Inc.
Mechthild Sander, Qualified Person –
Alfred E. Tiefenbacher
--VALUE ADDED MEDICINES--
A New Value Proposition for Patients, Healthcare
Practitioners and Systems
Chair | Christoph Stoller, SVP, Chief Operating Officer
GGM Europe – Teva Pharmaceuticals Europe B.V. and
Vice-President – Medicines for Europe
Panel
Mondher Toumi, Professor – University of Aix-
Marseille
Robert Andrew Johnstone, Patient Advocate
Sampreet Ramachandra, Director of Strategy –
Fresenius Kabi
Antonio Vaz Carneiro, Head – Centre for
Evidence-Based Medicine (CEMBE) - Faculty of
Medicine of the University of Lisbon
Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com
Follow us on
17:20
-
18:30
--WOMEN’S LEADERSHIP & PHARMA
Interactive session: Q&A with influential women in healthcare
Chair | Hanan J. Sboul, Secretary General – Jordanian Association of Pharmaceutical Manufacturers
Panel
Carol Lynch, Global Head of Biopharmaceuticals – Sandoz / Chair of the Biosimilar Medicines Group
Catarina Nobre, President – EPSA
Elisabeth Stampa, CEO – Medichem SA
Suzette Kox, Senior Director International – Biosimilar Medicines Group
Belinda Wood, CEO – Generic and Biosimilar Medicines Association (GBMA), Australia and Vice-Chair
of the IGBA Biosimilars Committee
19:30
Conference Dinner sponsored by
Friday 16 June
08:00
Networking Coffee
09:00
--OPENING ADDRESS—
Paulo Lilaia, President – Apogen (Portuguese Association for Generic and Biosimilar Medicines)
--OPENING SPEECH—
José Inácio Faria, MEP – EPP Portugal
09:20
--BUSINESS--
A Discussion with the Global Leaders and Analysts
Chair | John Hodgson, Executive Editor – In Vivo, Informa Pharma Intelligence Group
Panel
Elisabeth Stampa, CEO – Medichem
Enrique Ordieres, President – Cinfa
Jeremy B. Desai, CEO – Apotex Inc.
Frances Cloud, Founder – Pharmacloud
Randall Stanicky, Managing Director – RBC Capital Markets
Simon Goeller, Partner – McKinsey & Company
10:40
Networking Coffee Break
Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com
Follow us on
11:30 --EMERGING MARKETS—
Unlocking Pharma Growth – Emerging Markets
Chair | Rafael Enrique Maciel Martínez, President – AMEGI
Panel
Jean Mina, Associate Partner – McKinsey & Company
Abdallah Mazahreh, Marketing Director / MENA & Emerging Markets – Pharma International
Company
Vivian Frittelli, CEO – NAPM (South Africa)
Dilip G Shah, Secretary General – IPA (South Asia and India)
Keh Song Hock, Executive Director – Malaysian Organisation of Pharmaceutical Industries (Southeast
Asia)
Talgat Nurgozhin, Director – Center for Life Sciences, “National Laboratory “Astana”, Nazarbayev
University (Central Asia and Eastern Europe)
12:45
Networking Buffet Lunch sponsored by
14:00
--BIOSIMILAR MEDICINES--
Global Market Policies for Biosimilar Medicines
Chair | Belinda Wood, CEO – Generic and Biosimilar Medicines Association (GBMA), Australia
and Vice-Chair of the IGBA Biosimilars Committee
Panel
Maggie Dolan, Regional Pharmacy Procurement Specialist – NHS Commercial Solutions Surrey
Gillian Woollett, Senior Vice President – Avalere Health
Suzanne McGurn, Assistant Deputy Minister (ADM) and Executive Officer (EO) – Ontario Public Drug
Programs
Hiroyuki Sakamaki, Professor – Tokyo University of Science
Florian Turk, Global Head Payor Marketing, Sales and Engagement – Sandoz and Vice-Chair of the
Market Access Committee of the Biosimilar Medicines Group, a Medicines for Europe Sector Group
15:20
--CLOSING REMARKS--
Adrian van den Hoven, Chairman – IGBA
Please note that there will be simultaneous translation
English-Portuguese available.
Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com
Follow us on
SPONSORS
MEDIA PARTNERS